PAI Pharma Executive and Leadership Team

Kurt Orlofski, the Chief Executive Officer at PAI Pharma, directs the overarching corporate strategy and long-term vision for the organization. Orlofski guides PAI Pharma's expansion within the generic oral liquid medications and unit-dose pharmaceutical products sectors. This leadership involves ensuring the company maintains its position as a leading manufacturer of liquid generic pharmaceuticals in the United States healthcare market. Orlofski oversees the strategic development of product portfolios, including oral suspensions, syrups, injectable medicines, and patient-centric drug delivery solutions. The Chief Executive Officer ensures alignment with market demands from hospitals, retail pharmacies, long-term care facilities, and government healthcare systems. By focusing on innovation and quality, Kurt Orlofski drives the company's mission to provide essential prescription generic medicines and over-the-counter pharmaceutical products to a broad customer base across the United States.

Debra Cesard, the Chief Financial Officer at PAI Pharma, manages all financial operations and fiscal strategy for the company. Cesard oversees revenue generation through the development, manufacturing, packaging, and distribution of prescription generic medicines and over-the-counter pharmaceutical products. The Chief Financial Officer ensures robust financial planning, budgeting, and resource allocation to support PAI Pharma's growth in producing oral liquid and unit-dose medications. This role involves managing financial risk, optimizing capital structure, and ensuring compliance with all relevant financial regulations within the pharmaceutical manufacturing sector. Debra Cesard's financial oversight is critical for maintaining the company's operational efficiency and its ability to serve hospitals, retail pharmacies, and institutional healthcare providers throughout the United States. The Chief Financial Officer's expertise underpins the company's sustained market presence and profitability.

Brandon Rockwell, the President & Chief Operating Officer at PAI Pharma, executes the day-to-day operational strategies and ensures efficient manufacturing processes. Rockwell oversees the production of generic oral liquid medications, unit-dose pharmaceutical products, suspensions, syrups, and injectable medicines. The President & Chief Operating Officer drives operational excellence across all manufacturing facilities, focusing on quality control and timely delivery of products to hospitals, retail pharmacies, and long-term care facilities. This leadership position involves optimizing supply chain logistics and managing production schedules to meet the demands of the United States healthcare market. Brandon Rockwell's operational management ensures PAI Pharma's capacity to produce a wide range of pharmaceutical formulations, including oral solutions, elixirs, and semi-solid medications. The President & Chief Operating Officer's focus on efficiency supports the company's mission to be a leading provider of essential generic medicines.

Michael Craney, the President, Sales at PAI Pharma, directs all sales and business development activities across the United States. Craney spearheads the go-to-market strategies for PAI Pharma's extensive product portfolio, including generic oral liquid medications, unit-dose pharmaceutical products, and injectable medicines. The President, Sales oversees relationships with key customers such as retail pharmacy chains, independent pharmacies, acute care facilities, and government agencies. Michael Craney's leadership ensures that PAI Pharma effectively reaches hospitals, retail pharmacies, long-term care facilities, and institutional healthcare providers with its high-quality pharmaceutical offerings. This role involves driving revenue growth and expanding market penetration for prescription generic medicines and over-the-counter products. The President, Sales's focus on customer engagement and market expansion is vital to PAI Pharma's sustained success and its role as a leading manufacturer.

Michael Elliott, the President at PAI Pharma, drives strategic initiatives and market expansion for the company's specialized pharmaceutical products. Elliott oversees the development and execution of business strategies aimed at enhancing PAI Pharma's presence in the generic oral liquid medications and unit-dose pharmaceutical products markets. The President focuses on strengthening partnerships with healthcare providers, including hospitals, retail pharmacies, and long-term care facilities across the United States. Michael Elliott's leadership ensures that the company's product portfolio, encompassing syrups, suspensions, and injectable medicines, meets the evolving needs of the healthcare industry. This role involves identifying new market opportunities and fostering innovation in patient-centric drug delivery solutions. The President's strategic vision supports PAI Pharma's commitment to manufacturing high-quality, accessible prescription generic medicines and over-the-counter pharmaceutical products.

Annmarie Higgins, the Chief People Officer at PAI Pharma, leads all human capital strategies and organizational development initiatives. Higgins cultivates a high-performance culture that supports PAI Pharma's mission in manufacturing specialized pharmaceutical products. The Chief People Officer oversees talent acquisition, employee engagement, and professional development programs designed to attract and retain top talent within the pharmaceutical industry. Annmarie Higgins ensures that PAI Pharma's workforce is equipped with the skills necessary to produce high-quality oral liquid and unit-dose medications. This role involves fostering an environment that prioritizes safety, compliance, and innovation across all operational departments. The Chief People Officer's strategic approach to human resources strengthens the company's ability to serve healthcare providers nationwide, ensuring a dedicated team supports the production of essential generic medicines and patient-centric drug delivery solutions.